titlesubmit dateissue date
Now showing items 1-6 of 6
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases.
Suppressor of fused associates with dissemination patterns in patients with glioma
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide
The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas
Tumor-derived pericytes driven by EGFR mutations govern the vascular and immune microenvironment of gliomas.